In recent years, the manufacture of medicinal products for the European Union (EU) market increasingly occurs outside of the EU. While this trend is particularly noted for the manufacture of active substances, it is also evident that a similar trend applies to medicinal product manufacture.



Posted on the EMA website on 29 May 2015